PMID- 32696242 OWN - NLM STAT- MEDLINE DCOM- 20211015 LR - 20211015 IS - 1435-1463 (Electronic) IS - 0300-9564 (Linking) VI - 127 IP - 10 DP - 2020 Oct TI - Examination of plasma zonulin levels in bipolar I disorder: a case-control study with follow-up. PG - 1419-1426 LID - 10.1007/s00702-020-02234-7 [doi] AB - There is an accumulation in studies which strive to reveal zonulin's potential role in mental disorders. To date, one cross-sectional recent study examined zonulin in patients with bipolar disorders (BDs); however, its role still remains vague due to high fluctuation. Our aims are to determine plasma zonulin levels in exacerbation and treatment response periods, and to examine the associations between zonulin and symptom severity in BD. 30 patients with BD type I and 29 healthy controls participated in the current study. Socio-demographic form, Young Mania Rating Scale (YMRS), and Hamilton Depression Rating Scale (HAM-D) were administered. Enzyme-linked immune assay (ELISA) method was used to measure the plasma zonulin levels of the participants. The groups did not differ in plasma zonulin-level comparisons. Plasma zonulin did not alter between the exacerbation and treatment response periods of the patients. Besides, no associations were found between plasma zonulin-level and disease symptoms. Intestinal barrier integrity was not found to be altered among patients with BD type I. The lack of alterations in plasma zonulin level between different periods may be attributable to several factors. One possible factor might be the ELISA method which can detect other proteins (e.g., properdin) rather than zonulin. Therefore, it might fail to indicate direct observation of intestinal permeability. However, future study designs with more accurate estimation of zonulin in a larger sample may provide a different perspective on intestinal permeability's possible role in BD etiology. FAU - Aydin, Orkun AU - Aydin O AUID- ORCID: 0000-0003-0869-7394 AD - Department of Psychology, International University of Sarajevo, Faculty of Arts and Social Sciences, Hrasnicka cesta 15, Ilidza, 71210, Sarajevo, Bosnia and Herzegovina. oaydin@ius.edu.ba. FAU - Kocabas, Tugba AU - Kocabas T AD - Department of Psychiatry, Celal Bayar University, Faculty of Medicine, Manisa, Turkey. FAU - Sarandol, Asli AU - Sarandol A AD - Department of Psychiatry, Uludag University, Faculty of Medicine, Bursa, Turkey. FAU - Tastan, Ismail AU - Tastan I AD - Department of Biochemistry, Celal Bayar University, Faculty of Medicine, Manisa, Turkey. FAU - Onur, Ece AU - Onur E AD - Department of Biochemistry, Celal Bayar University, Faculty of Medicine, Manisa, Turkey. FAU - Aydemir, Omer AU - Aydemir O AD - Department of Psychiatry, Celal Bayar University, Faculty of Medicine, Manisa, Turkey. FAU - Esen-Danaci, Aysen AU - Esen-Danaci A AD - Department of Psychiatry, Celal Bayar University, Faculty of Medicine, Manisa, Turkey. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200721 PL - Austria TA - J Neural Transm (Vienna) JT - Journal of neural transmission (Vienna, Austria : 1996) JID - 9702341 RN - 0 (Haptoglobins) RN - 0 (Protein Precursors) RN - 0 (zonulin) SB - IM MH - *Bipolar Disorder/diagnosis MH - Case-Control Studies MH - Cross-Sectional Studies MH - Follow-Up Studies MH - Haptoglobins MH - Humans MH - Protein Precursors OTO - NOTNLM OT - Autoimmune OT - Bipolar disorder OT - Haptoglobin OT - Inflammation OT - Symptom severity OT - Zonulin EDAT- 2020/07/23 06:00 MHDA- 2021/10/16 06:00 CRDT- 2020/07/23 06:00 PHST- 2020/05/23 00:00 [received] PHST- 2020/07/14 00:00 [accepted] PHST- 2020/07/23 06:00 [pubmed] PHST- 2021/10/16 06:00 [medline] PHST- 2020/07/23 06:00 [entrez] AID - 10.1007/s00702-020-02234-7 [pii] AID - 10.1007/s00702-020-02234-7 [doi] PST - ppublish SO - J Neural Transm (Vienna). 2020 Oct;127(10):1419-1426. doi: 10.1007/s00702-020-02234-7. Epub 2020 Jul 21.